000 01518 a2200457 4500
005 20250516224236.0
264 0 _c20150810
008 201508s 0 0 eng d
022 _a1868-8551
024 7 _a10.14573/altex.1405151
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndersen, Melvin E
245 0 0 _aDeveloping microphysiological systems for use as regulatory tools--challenges and opportunities.
_h[electronic resource]
260 _bALTEX
_c2014
300 _a364-7 p.
_bdigital
500 _aPublication Type: Congress
650 0 4 _aAnimal Testing Alternatives
_xlegislation & jurisprudence
650 0 4 _aGovernment Regulation
650 0 4 _aLab-On-A-Chip Devices
_xtrends
650 0 4 _aMicrofluidic Analytical Techniques
_xmethods
650 0 4 _aRisk Assessment
650 0 4 _aToxicity Tests
_xtrends
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aBetts, Kellyn
700 1 _aDragan, Yvonne
700 1 _aFitzpatrick, Suzanne
700 1 _aGoodman, Jesse L
700 1 _aHartung, Thomas
700 1 _aHimmelfarb, Jonathan
700 1 _aIngber, Donald E
700 1 _aJacobs, Abigail
700 1 _aKavlock, Robert
700 1 _aKolaja, Kyle
700 1 _aStevens, James L
700 1 _aTagle, Dan
700 1 _aLansing Taylor, D
700 1 _aThrockmorton, Douglas
773 0 _tALTEX
_gvol. 31
_gno. 3
_gp. 364-7
856 4 0 _uhttps://doi.org/10.14573/altex.1405151
_zAvailable from publisher's website
999 _c24042394
_d24042394